New Year’s Day price hikes on blockbuster drugs set the stage for a big debate
Allergan, Pfizer, Bristol-Myers Squibb, Biogen and other top drugmakers all celebrated the New Year’s with a traditional boost in the price of their top drugs.
For Allergan, there was an across-the-board hike of 9.5% for 7 of its top 10 products. Biogen’s Tecfidera went up 6%, according to a roster of new drug prices assembled January 1 by Umer Raffat from Evercore ISI. Jardiance and Tradjenta at Eli Lilly went up 6% — after they triggered a 2% hike for Alimta just before New Year’s. And so on….
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.